simplify.education

Pharmacology / ophthalmology · BEGINNER LESSON

ROCK inhibitor

A ROCK inhibitor is a small-molecule drug that blocks Rho-associated protein kinase (ROCK), a signaling enzyme involved in cell shape, contraction, adhesion, and movement. In the eye, these drugs have been used to lower intraocular pressure and are being studied for helping corneal endothelial repair.

What it is

ROCK inhibitor is the name for a drug that blocks Rho-associated protein kinase, often shortened to ROCK. ROCK is a signaling enzyme downstream of RhoA, a small GTPase, and it helps control how cells contract, stick together, and move. In eye medicine, ROCK inhibitors are discussed mainly as pressure-lowering drugs and as possible helpers for damaged corneal endothelium, the cell layer that keeps the cornea clear by moving fluid out of it. [0,1,2]

[1] Rho-Kinase Inhibitor—A Molecule for Pharmacological ... - PMC [2] Efficacy, effectiveness, and safety of rho-kinase inhibitors in ... [3] Rho/ROCK Signaling Pathway in Kidney Diseases: Mechanisms and ...

How it works

The ROCK pathway affects the cytoskeleton, the internal structure that helps cells keep shape and generate force. When ROCK is active, it can promote actomyosin contraction and change junctions between cells. Blocking ROCK relaxes trabecular meshwork cells, which can reduce outflow resistance so aqueous humor, the fluid inside the front of the eye, drains more easily through Schlemm’s canal. In corneal studies, ROCK inhibition may also stabilize cell-cell junctions, reduce leakage between cells, and support pump-related proteins such as Na+/K+-ATPase, bicarbonate transporters, and aquaporins. [0,1,2]

[1] Rho-Kinase Inhibitor—A Molecule for Pharmacological ... - PMC [2] Efficacy, effectiveness, and safety of rho-kinase inhibitors in ... [3] Rho/ROCK Signaling Pathway in Kidney Diseases: Mechanisms and ...

Evidence and use

The best-established use in these excerpts is lowering intraocular pressure in glaucoma and ocular hypertension, including cases linked to uveitis. The sources also describe early clinical and experimental findings suggesting possible benefit for corneal edema when some endothelial reserve remains, but they emphasize that the clinical evidence is still limited and not yet definitive. [0,1]

[1] Rho-Kinase Inhibitor—A Molecule for Pharmacological ... - PMC [2] Efficacy, effectiveness, and safety of rho-kinase inhibitors in ...

Limitations

These drugs are promising, but the evidence base is still incomplete. The corneal benefit is not fully explained by mechanism, and the reviewed studies often have small sample sizes or limited designs. The kidney review also notes that many ROCK inhibitors are small molecules with imperfect target selectivity, which can raise off-target side effects, and that larger controlled trials are needed in several fields. [0,1,2]

[1] Rho-Kinase Inhibitor—A Molecule for Pharmacological ... - PMC [2] Efficacy, effectiveness, and safety of rho-kinase inhibitors in ... [3] Rho/ROCK Signaling Pathway in Kidney Diseases: Mechanisms and ...

SEE THE IDEA

How a ROCK inhibitor can affect the eye

ROCK signaling drives cell contraction; inhibition relaxes cells and can change fluid handling.

A simplified pathway from ROCK blockade to eye-fluid effects and possible corneal benefits.

TRY IT YOURSELF

Test your understanding

Choose an answer, then check the explanation.

0 of 3 questions answered
01 What is a ROCK inhibitor?
02 A patient with glaucoma is given a ROCK inhibitor. Which effect best matches the sources?
03 Which scenario best fits the corneal evidence described in the sources?

PUT IT TOGETHER

Match each concept to its meaning

Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.

Sources and further reading

This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.

  1. Rho-Kinase Inhibitor—A Molecule for Pharmacological ... - PMC
  2. Efficacy, effectiveness, and safety of rho-kinase inhibitors in ...
  3. Rho/ROCK Signaling Pathway in Kidney Diseases: Mechanisms and ...
Apply this to a paper →